by Vineti | March 9, 2020
Vineti is thrilled to announce that Phil Calvin has joined Vineti as our Chief Technology Officer. A veteran technology executive at Salesforce, other SaaS innovation companies, and his own start-ups, Phil brings more than 25 years of software…
by Heidi Hagen and Subbu Viswanathan | March 3, 2020
This post is the third in a five-part series on Quality Management Systems (including cGMP and Quality Risk Management) for personalized therapies, such as cell therapies, gene therapies, or neoantigen cancer vaccines. This series focuses…
by Amy DuRoss | March 2, 2020
At our core, Vineti is a technology company focused on health, well-being, and patient safety. Our software platform manages critical CAR-T cell therapies and other personalized therapeutics on behalf of patients daily.
That mission-critical work…
by Heidi Hagen and Subbu Viswanathan | February 25, 2020
This post is the second in a five-part series on Quality Management Systems (including cGMP and Quality Risk Management) for personalized therapies, such as cell therapies, gene therapies, or neoantigen cancer vaccines. This series focuses…
by Heidi Hagen and Subbu Viswanathan | February 25, 2020
This post is the first in a five-part series on Quality Management Systems (including cGMP and Quality Risk Management) for personalized therapies, such as cell therapies, gene therapies, or neoantigen cancer vaccines. This series focuses…